Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Daily News

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

L.A. McKeown

October 01, 2024

News Daily News

Kidney Events High in Older Patients After HF Hospitalization

L.A. McKeown

May 30, 2024

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Daily News

Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2

Yael L. Maxwell

November 03, 2022

News Daily News

Enoxaparin Tops Aspirin for Preventing VTE After Hip or Knee Arthroplasty

Todd Neale

August 25, 2022

News Daily News

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

Yael L. Maxwell

July 15, 2022

News Daily News

Myocarditis Risk Varies by COVID-19 Vaccine Type, Dosing Interval

Todd Neale

June 28, 2022

News Daily News

Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE

Michael O'Riordan

June 17, 2022

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Daily News

High Levels of Lp(a) Linked to Increased Ischemic Stroke Risk

Michael O'Riordan

July 01, 2019

News Daily News

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Michael O'Riordan

January 09, 2018

News Daily News

Testosterone Therapy Raises Risk of VTE Early but Not Beyond 6 Months

Michael O'Riordan

December 01, 2016

Advertisement

Use of Secondary CVD Prevention Meds Still Meager Worldwide

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

Kidney Events High in Older Patients After HF Hospitalization

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2

Enoxaparin Tops Aspirin for Preventing VTE After Hip or Knee Arthroplasty

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

Myocarditis Risk Varies by COVID-19 Vaccine Type, Dosing Interval

Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

High Levels of Lp(a) Linked to Increased Ischemic Stroke Risk

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Testosterone Therapy Raises Risk of VTE Early but Not Beyond 6 Months

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content